From Wikipedia, the free encyclopedia
Jump to: navigation,
search
Sulfamerazine
 |
| Systematic (IUPAC) name |
4-amino-N-(4-methylpyrimidin-2-yl)
benzenesulfonamide |
| Identifiers |
| CAS number |
127-79-7 |
| ATC code |
J01ED07 |
| PubChem |
CID 5325 |
| Chemical data |
| Formula |
C11H12N4O2S |
| Mol. mass |
264.305 g/mol |
| Therapeutic considerations |
| Pregnancy cat. |
? |
| Legal status |
|
 Y(what is this?) (verify)
|
Sulfamerazine is a sulfonamide antibacterial.
|
Antibiotics and chemotherapeutics for dermatological use (D06) |
|
| Antibiotics |
|
Tetracycline and derivatives
|
Demeclocycline · Chlortetracycline · Oxytetracycline · Tetracycline
|
|
|
Others
|
Amphenicol: Chloramphenicol
Aminoglycosides: Neomycin · Gentamicin · Amikacin
Quinolone: Nadifloxacin
Streptogramin: Virginiamycin
Rifamycin: Rifaximin
other: Fusidic acid · Bacitracin · Tyrothricin · Mupirocin
|
|
|
| Chemotherapeutics |
|
Sulfonamides
|
Silver sulfadiazine · Sulfathiazole · Mafenide · Sulfamethizole · Sulfanilamide · Sulfamerazine
|
|
|
Antivirals
|
Aciclovir · Penciclovir · Idoxuridine · Edoxudine
Imiquimod/Resiquimod · Podophyllotoxin
Docosanol · Tromantadine · Inosine · Lysozyme · Ibacitabine
|
|
|
Other
|
Metronidazole
|
|
|
|
|
|
noco(i,b,d,q,u,r,p,k,c,v)/cong/tumr(n,e,d), sysi/epon
|
|
|
|
|
|
Antibacterials: nucleic acid inhibitors (J01E, J01M) |
|
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis) |
|
DR inhibitor
|
2,4-Diaminopyrimidine (Trimethoprim#, Brodimoprim, Tetroxoprim, Iclaprim†)
|
|
|
Sulfonamides
(DS inhibitor)
|
|
Short-
acting
|
Sulfaisodimidine · Sulfamethizole · Sulfadimidine · Sulfapyridine · Sulfafurazole · Sulfanilamide (Prontosil) · Sulfathiazole · Sulfathiourea
|
|
|
Intermediate-
acting
|
Sulfamethoxazole · Sulfadiazine# · Sulfamoxole
|
|
|
Long-
acting
|
Sulfadimethoxine · Sulfalene · Sulfametomidine · Sulfametoxydiazine · Sulfamethoxypyridazine · Sulfaperin · Sulfamerazine · Sulfaphenazole · Sulfamazone
|
|
|
|
Other/ungrouped
|
sulfanilamide (Sulfacetamide, Sulfametrole)
|
|
|
Combinations
|
Sulfamethoxazole and trimethoprim#
|
|
|
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication) |
|
1st generation
|
Cinoxacin‡ · Flumequine · Nalidixic acid · Oxolinic acid · Pipemidic acid · Piromidic acid · Rosoxacin
|
|
|
Fluoroquinolones
|
|
2nd
generation
|
Ciprofloxacin# · Enoxacin‡ · Fleroxacin‡ · Lomefloxacin · Nadifloxacin · Ofloxacin · Norfloxacin · Pefloxacin · Rufloxacin
|
|
|
3rd
generation
|
Balofloxacin · Grepafloxacin‡ · Levofloxacin · Pazufloxacin · Sparfloxacin‡ · Temafloxacin‡ · Tosufloxacin
|
|
|
4th
generation
|
Besifloxacin · Clinafloxacin† · Garenoxacin · Gemifloxacin · Moxifloxacin · Gatifloxacin‡ · Sitafloxacin · Trovafloxacin‡/Alatrofloxacin‡ · Prulifloxacin
|
|
|
Veterinary
|
Danofloxacin · Difloxacin · Enrofloxacin · Ibafloxacin · Marbofloxacin · Orbifloxacin · Pradofloxacin · Sarafloxacin
|
|
|
Related agents (DG)
|
Aminocoumarins: Novobiocin
|
|
|
|
Anaerobic DNA
inhibitors |
|
Nitro- imidazole derivatives
|
Metronidazole# · Tinidazole · Ornidazole
|
|
|
Nitrofuran derivatives
|
Furazolidone‡ · Nitrofurantoin# · Nifurtoinol
|
|
|
| RNA synthesis |
|
Rifamycins/
RNA polymerase
|
Rifampicin · Rifabutin · Rifapentine · Rifaximin
|
|
|
#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III
|
|
|
gr+f/gr+a(t)/gr-p(c)/gr-o
|
|
|
|
|
